Rankings
▼
Calendar
SAVA FY 2015 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$115M
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$45,000
Operating Income
-$14M
Net Income
-$14M
EPS (Diluted)
$-2.16
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$32M
Total Liabilities
$3M
Stockholders' Equity
$29M
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$45,000
-$7,306
-515.9%
Operating Income
-$14M
-$12M
-14.2%
Net Income
-$14M
-$12M
-14.2%
← FY 2014
All Quarters
Q4 2015 →